CorMedix’s CRMD lead drug, DefenCath (Taurolidine + Heparin), is currently its only marketed product that generates revenues for the company. The FDA approved CorMedix’s DefenCath in late 2023 as the ...

Reliance Industries Ltd’s (RIL’s) digital arm Jio Platforms posted a 13% YoY increase in its consolidated net profit to INR 7,379 Cr in Q2 FY26. On a sequential basis, PAT increased 4% from INR 7,110 ...

The stock got listed at INR 646.5 on the BSE, marginally lower than the issue price of INR 648 On the NSE, the shares opened slightly above the issue price at INR 650 The company’s IPO closed with an ...

It’s sad but true that travel often takes a backseat when it comes to gadgets and let’s be specific iphones! But think if we told you that the cost of an iPhone 17 which is (around INR 83,000) could ...

Diwali is approaching fast, and those planning to escape the city pollution, and get away to some place for a change, remember there are endless options to spoil you. Here, we guide you to organise ...

The Indian Rupee rises against the US Dollar as the USD/INR pair retraces to near 88.74. A slight improvement in FIIs' sentiment towards the Indian stock market could lend support to the Indian Rupee.

The Indian Rupee opens on a weak note against the US Dollar around 88.90 as the Greenback gains on easing US-China trade tensions. US President Trump and Chinese leader Xi Jinping are set to meet in ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

CORPUS CHRISTI, Texas — The case of 14 babies who received accidental overdoses while in intensive care has raised new questions about how a common blood-thinning medication could be given to infants ...